Targeted deletion of PD-1 in myeloid cells induces antitumor immunity.
Sci Immunol. 2020 Jan 3;5(43):eaay1863. doi: 10.1126/sciimmunol.aay1863.
Sci Immunol. 2020.
PMID: 31901074
Free PMC article.